Loading asset research
Absci Corporation Common Stock
ABSINasdaq · USD · StocksQuote as of · Exchange session not verified$9.50
+18.16%
Today
ABSI
Loading 1D prices…
Market cap
$1.6B
Volume
8.7M
52w high
$12.0652w low
$2.24Company profile
Absci Corporation Common Stock
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector
Other
Industry
Services-Commercial Physical & Biological Research
Exchange
Nasdaq
Display currency
USD
Location
VANCOUVER, WA, United States
Employees
140
Fiscal year end
1231
CIK
1672688
Session & valuation
Open$8.30
Previous close$8.04
Day high$9.83
Day low$8.28
30-day avg. volume3M
Outstanding shares171.6M
Diluted EPS-$0.84
Latest annual period
P/E (trailing)-11.31
P/E (forward)-13.73
Price / book6.46
Beta2.44
Dividend yield—
Deterministic peer set
Companies with SEC SIC 8731
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OABIOmniAb Inc. Common Stock | $645.5M | $18.7M | -347.04% | -$0.57 | +1.26% | Buy |
| NRCNRC Health Common Stock | $461.6M | $137.4M | +8.44% | $50.00 | -5.35% | Buy |
| ICLRICON plc Ordinary Shares | $12.7B | $8.3B | +2.78% | $2.90 | -5.65% | Buy |
| CRLCharles River Laboratories International Inc. Common Stock | $13.4B | $4B | -3.59% | -$2.91 | +1.11% | Buy |
| MEDPMedpace Holdings Inc. Common Stock | $17.1B | $2.5B | +17.83% | $15.28 | -0.64% | Hold |